trombosis vena dalam (tvd) raehanul bahraen...

8
103 DAFTAR PUSTAKA Agutter, P. S., & Malone, P. C. (2012). Aetiology of Deep Venous Thrombosis - Implications for Prophylaxis. Intechopen. ISBN: 978 953 51 0161 6 Alexey G. Gerbst, Nadezhda E. Ustyuzhanina and Nikolay E. Nifantiev (2015). Computational study of the possible formation of the ternary complex between thrombin, antithrombin III and fucosylated chondroitin sulfates. Mendeleev Commun. , 25, 420–421 Alikhan, R., Cohen, A.T., Combe, S., Samama, M.-M.M., Desjardins, L., Eldor, A., et al. (2004) Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness. Int med Jour. [Online] 164 (9), 963–968. Available from: doi:10.1001/archinte.164.9.963. Allman-Farinelli, M.A. (2011) Obesity and venous thrombosis: a review. Semin Thromb Hemost. 2011 Nov;37(8):903-7 Angchaisuksiri, P. (2011). Venous thromboembolism in Asia -an unrecognised and under-treated problem?. J Thromb and Haemost. 106 (4), 585–590. Available from: doi:10.1160/TH11-03-0184. Aoyagi T, Terracina K, Raza A, Matsubara H & Takabe K (2015). Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015 Apr 15; 7(4): 17– 29. Arnesen, H., Dahl, O.E., Aspelin, T., Seljeflot, I., Kierulf, P. & Lyberg, T. (2003) Sustained prothrombotic profile after hip replacement surgery : the influence of prolonged prophylaxis with dalteparin. J Thromb and Haemost. [Online] 2971– 975. Available from: doi:10.1046/j.1538-7933.2003.00111.x. Ay, C., Pabinger, I., (2016). Predictive Potential Of Haemostatic Biomarkers for Venous Thromboembolism in Cancer Patients. Thromb Researc. 129 Suppl 1:S6-9. Ay, C., Pabinger, I., & Cohen, A. T. (2017). Cancer-associated venous thromboembolism : Burden , mechanisms , and management. J Thromb Haemost, 117(2), 219–230. Bern, M.M., Hazel, D., Reilly, D.T., Adcock, D.M. & Hou, L. (2015). Effects of anticoagulation on markers of activation of clotting following major orthopedic surgery. Intert J. Lab. Hematology. [Online] 37 (5), 673–679. Available from: doi:10.1111/ijlh.12384. Bick, R.L. (2003). Cancer-Associated Thrombosis. Engl. J. med. 349(2). Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA (1990). A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol.1990 Apr;74(4):471-9. KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIEN TROMBOSIS VENA DALAM (TVD) RAEHANUL BAHRAEN Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

Upload: vuphuc

Post on 13-Jul-2019

214 views

Category:

Documents


0 download

TRANSCRIPT

103

DAFTAR PUSTAKA

Agutter, P. S., & Malone, P. C. (2012). Aetiology of Deep Venous Thrombosis -

Implications for Prophylaxis. Intechopen. ISBN: 978 953 51 0161 6

Alexey G. Gerbst, Nadezhda E. Ustyuzhanina and Nikolay E. Nifantiev (2015). Computational study of the possible formation of the ternary complex between

thrombin, antithrombin III and fucosylated chondroitin sulfates. Mendeleev

Commun. , 25, 420–421

Alikhan, R., Cohen, A.T., Combe, S., Samama, M.-M.M., Desjardins, L., Eldor, A.,

et al. (2004) Risk Factors for Venous Thromboembolism in Hospitalized

Patients With Acute Medical Illness. Int med Jour. [Online] 164 (9), 963–968.

Available from: doi:10.1001/archinte.164.9.963.

Allman-Farinelli, M.A. (2011) Obesity and venous thrombosis: a review. Semin

Thromb Hemost. 2011 Nov;37(8):903-7

Angchaisuksiri, P. (2011). Venous thromboembolism in Asia -an unrecognised and

under-treated problem?. J Thromb and Haemost. 106 (4), 585–590. Available

from: doi:10.1160/TH11-03-0184.

Aoyagi T, Terracina K, Raza A, Matsubara H & Takabe K (2015). Cancer cachexia,

mechanism and treatment. World J Gastrointest Oncol. 2015 Apr 15; 7(4): 17–

29.

Arnesen, H., Dahl, O.E., Aspelin, T., Seljeflot, I., Kierulf, P. & Lyberg, T. (2003)

Sustained prothrombotic profile after hip replacement surgery : the influence of

prolonged prophylaxis with dalteparin. J Thromb and Haemost. [Online] 2971–

975. Available from: doi:10.1046/j.1538-7933.2003.00111.x.

Ay, C., Pabinger, I., (2016). Predictive Potential Of Haemostatic Biomarkers for

Venous Thromboembolism in Cancer Patients. Thromb Researc. 129 Suppl

1:S6-9.

Ay, C., Pabinger, I., & Cohen, A. T. (2017). Cancer-associated venous

thromboembolism : Burden , mechanisms , and management. J Thromb

Haemost, 117(2), 219–230.

Bern, M.M., Hazel, D., Reilly, D.T., Adcock, D.M. & Hou, L. (2015). Effects of

anticoagulation on markers of activation of clotting following major orthopedic

surgery. Intert J. Lab. Hematology. [Online] 37 (5), 673–679. Available from:

doi:10.1111/ijlh.12384.

Bick, R.L. (2003). Cancer-Associated Thrombosis. Engl. J. med. 349(2).

Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA (1990). A

comparative evaluation of assays for markers of activated coagulation and/or

fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin

fragment E antigen. Br J Haematol.1990 Apr;74(4):471-9.

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

104

Chen, C., Li, G., Liu, Y. De, & Gu, Y. J. (2014). A new D-dimer cutoff value to

improve the exclusion of deep vein thrombosis in cancer patients. As Pac J of

Canc Prevent, 15, 1655–1658. https://doi.org/10.7314/APJCP.2014.15.4.1655

Chen, C.-Y. & Liao, K.-M. (2015) The Incidence of Deep Vein Thrombosis in Asian

Patients With Chronic Obstructive Pulmonary Disease. Medicine J. 94 (44), 1–

6. Available from: doi:10.1097/MD.0000000000001741.

Coachrom diagnostica. (2011). Matched-Pair Antibody Set for ELISA of human

Thrombin-Antithrombin complex (TAT).

Cusabio. (2016). Thrombin-Antithrombin Complex ELISA Kit.

Dahlan, M.S., (2009). Statistik untuk Kedokteran dan Kesehatan. 1-242.

Davie EW, Kulman JD (2006). An overview of the structure and function of

thrombin. Semin Thromb Hemost. 2006 Apr;32 Suppl 1:3-15.

Dehart. (2013). Deep venous thrombosis and pulmonary embolism, Available

at:http://libaccess.mcmaster.ca/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T

=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2013379816

Dentali, F., Di Minno, M.N.D., Turato, S., Crestani, S., Ambrosino, P., Bonfanti, C.,

et al. (2014) Role of ABO blood group and of other risk factors on the presence

of residual vein obstruction after deep-vein thrombosis. Thromb researc.

[Online] 134 (2), 264–267. Available from: doi:10.1016/j.thromres.2014.05.016

[Accessed: 27 June 2016].

Di Nisio, M., van Es, N. & Büller, H.R. (2016). Deep vein thrombosis and pulmonary

embolism. The Lancet, 35 , p.2015. Available at:

http://linkinghub.elsevier.com/retrieve/pii/S0140673616305141\nhttp://www.nc

bi.nlm.nih.gov/pubmed/27375038\nhttp://linkinghub.elsevier.com/retrieve/pii/S

0140673616305141.

Donnellan, E., & Khorana, A. A. (2017). Cancer and Venous Thromboembolic

Disease: A Review. The Oncologist, 22(2), 199–207.

https://doi.org/10.1634/theoncologist.2016-0214

Esmon, C.T. (2009). Basic Mechanisms and Pathogenesis of Venous Thrombosis.

Blood reviews. [Online] 23 (5), 225–229. Available from:

doi:10.1016/j.blre.2009.07.002.

Fang, C., Cohen, H.W. & Billett, H.H. (2012). Race, ABO blood group, and venous

thromboembolism risk: not black and white. Transfus J. [Online] 1–6. Available

from: doi:10.1111/j.1537-2995.2012.03665.x.

Ghoshal K., Bhattacharyya M. (2014). Overview of Platelet Physiology: Its

Hemostatic and Nonhemostatic Role in Disease Pathogenesis. Scientific World

J.;1-16.

Gomes, F. G., Sandim, V., Almeida, V. H., Rondon, A. M. R., Succar, B. B., Hottz,

E. D., Monteiro, R. Q. (2017). Breast-cancer extracellular vesicles induce

platelet activation and aggregation by tissue factor-independent and -dependent

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

105

mechanisms. Thromb Researc, 159 (September), 24–32.

https://doi.org/10.1016/j.thromres.2017.09.019

Hall. (2016). Chapter 37 – Hemostasis and Blood Coagulation in: Guyton and Hall

Textbook of Medical Physiology. Thirteenth edition., Philadelphia. Elsevier.

Handin RI, Lux IV SE and Stossel TP. (2003). Blood: Principles and Practice of

Hematology, 2nd. ed., Lippincott Williams & Wilkin, Philadelphia.

Hansson, P.-O. (1997) Deep Vein Thrombosis and Pulmonary Embolism in the

General Population. J Intern Med. [Online] 157 (15), 1665. Available from:

doi:10.1001/archinte.1997.00440360079008.

Hartono, F. & HD, I. (2011). Incidence of Deep Vein Thrombosis Post High Risk

Orthopaedic Surgery Without Thromboprophylaxis. J. IndoMed Ass. 61(06).

Heit et al., (2006). Trends in the incidence of deep vein thrombosis and pulmonary

embolism: a 35-year population based study. Blood J, 108:403a, 2006.

Hejrati, M., Farsi, N., & Joorgholami, M. (2013). Deep Vein Thrombosis,

Demographic Characteristics and Risk Factors in Iran. Galen Med. Jour. 2(4),

135–140.

Hernandez, W., Gamazon, E. R., Smithberger, E., Brien, T. J. O., Harralson, A. F.,

Tuck, Perera. (2016). Novel genetic predictors of venous thromboembolism risk

in African Americans. Short title: Genetic risk factors for venous

thromboembolism. Blood J. 127(15), pp.1923–1930.

Hirsh J. (2002). How we diagnose and treat deep vein thrombosis. Blood J. 2002.

99(9):3102-10

Hoffman, M. & Monroe, D.M. (2001) A Cell-based Model of Hemostasis. Thromb

Haemost. [Online] 85958–965. Available from:

doi:10.2174/0929867033457728.

Hoppensteadt D, Tsuruta K, Cunanan J, Hirman J, Kaul I, Osawa Y, Fareed J. (2014).

Thrombin generation mediators and markers in sepsis-associated coagulopathy

and their modulation by recombinant thrombomodulin. Clin Appl Thromb

Hemost. Mar;20(2):129-35. doi: 10.1177/1076029613492875.

Huang R., (2015). Disorders of hemostasis. Perioper Med Consult, pp.127–134.

Jensen, R. (2002). Clinical Presentation of Arterial Thrombosis vs. Venous

Thrombosis. C. Hem Review. 16 (8), 1–6.

Kang, J., Jiang, X. & Wu, B. (2015) Analysis of risk factors for lower-limb deep

venous thrombosis in old patients after knee arthroplasty. Chinese Med J.

[Online] 128 (10), 1358–1362. Available from: doi:10.4103/0366-6999.156782.

Khadijah Ismail, S., & Higgins, J. R. (2011). Hemostasis in pre-eclampsia. Thromb

and Hemost. 37(2), 111–117. https://doi.org/10.1055/s-0030-1270336

Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.-U., Burfeind, P., et al.

(2006). Targeting coagulation factor XII provides protection from pathological

thrombosis in cerebral ischemia without interfering with hemostasis. J. exp

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

106

medicine. [Online] 203 (3), 513–518. Available from:

doi:10.1084/jem.20052458.

Kline, J., (2014). Pulmonary Embolism and Deep Vein Thrombosis Eighth Edition.,

Elsevier Inc. Available at: http://dx.doi.org/10.1016/B978-1-4557-0605-

1.00088-9.

Knepper JP, Wakefield TW. (2014). Acute deep venous thrombosis: pathophysiology

and natural history. In: Cronenwett JL, Johnston KW eds. Rutherford’s

Vascular Surgery 1. 8th ed. Philadelphia: Elsevier: 745-9

Knorre, DG; Kudryashova, NV; Godovikova, TS (2009). Chemical and Functional

Aspects of Posttranslational Modification of Proteins. Acta Nature. 1 (3): 29-51.

Lacapra, S., Arkel, Y. S., Ku, D. H., Gibson, D., Lake, C., & Lam, X. (2000). The use

of thrombus precursor protein , thrombin antithrombin in the exclusion of

proximal deep vein thrombosis and pulmonary embolism. Blood Coagul

Fibrinolys. 11(4), 371–377.

Lee JA, Zierler B, Zierler RE (2012). The Risk Factors and Clinical Outcomes of

Upper Extremity Deep Vein Thrombosis. Sage Jour. Vol. 46:2, 139-144

Lee, S., Hwang, J., Kim, Y., Yoon, P.W., Ahn, J. & Yoo, J.J. (2016) Venous

Thromboembolism Following Hip and Knee Replacement Arthroplasty in

Korea : A Nationwide Study Based on Claims Registry. J Korean Med Sci.

3180–88.

Lee, S. Y., Niikura, T., Iwakura, T., Sakai, Y., Kuroda, R., & Kurosaka, M. (2017).

Thrombin–antithrombin III complex tests. J Orthop Surg. 25(1),

17084061668450. https://doi.org/10.1177/0170840616684501

Lim., (2012). Chapter 144 - Venous Thromboembolism. In Hematology: Basic

Principles and Practice 6th ed. Elsevier Inc., pp. 2039–2047.e4. Available at:

http://dx.doi.org/10.1016/B978-1-4377-2928-3.00144-1.

Lopez, J.A., Kearon, C. & Lee, A.Y.Y. (2004) Deep Venous Thrombosis.

Hematology J. [Online] 2004 (1), 439–456. Available from:

doi:10.1182/asheducation-2004.1.439. Lurie & Paolini., (2014). Acute Deep Venous Thrombosis : Clinical and Diagnostic

Evaluation Eighth Edi., Elsevier Inc. Available at:

http://dx.doi.org/10.1016/B978-1-4557-5304-8.00050-9.

Mao, X., Ait-Aissa, K., Lagrange, J., Youcef, G., & Louis, H. (2012). Hypertension,

hypercoagulability and the metabolic syndrome: A cluster of risk factors for

cardiovascular disease. Bio-Med Mater Eng. 22(1–3), 35–48.

https://doi.org/10.3233/BME-2012-0688

Małyszko, J., & Tymcio, J. (2008). Thrombin activatable fibrinolysis inhibitor and

other hemostatic parameters in patients with essential arterial hypertension.

Polskie J. 2008; 118 (1-2)

Marchant K, Corcoran G. (2002). The Laboratory Diagnosis of Platelet Disorders,

Arch Pathol Lad Med. 126. Feb. Ohio

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

107

Marder, V.J., Aird, W.C., Bennett, J.S., Schulman, A. & White, G. (2013).

Hemostasis and Thrombosis. 6th edition. Philadelphia. Lipiincott Williams &

Wilkins.

Maurice, E., & Sié, P. (1991). Prothrombin fragment 1+2, thrombin-antithrombin

complexes and D-dimers in acute deep vein thrombosis: effects of heparin

treatment. British J Haem. 78. 421-424. Available at

https://doi.org/10.1111/j.1365-2141.1991.tb04458.x

Mitchell., (2015). Hemodynamic Disorders, Thromboembolic Disease, and Shock. In

Robbins & Cotran Pathologic Basis of Disease. Aster J. Elsevier, pp. 113–135

Michiels, C. & Arnould, T. (2000) Endothelial cell responses to hypoxia : initiation of

a cascade of cellular interactions. Biochim Biophys Acta. Jun 2;1497(1):1-10.

Milburn, J. A., Ford, I., Mutch, N. J., Fluck, N., & Brittenden, J. (2013). Thrombin-

Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients

Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective

Analysis. PLos one, 8(7), 1–7. https://doi.org/10.1371/journal.pone.0067799

Napolitano, M., Schamaier, A.. & Kessler, C. (2016). Coagulation and Fibrinolysis.

23th edition. [Online]. Elsevier Inc. Available from:

doi:http://dx.doi.org/10.1016/B978-0-323-29568-0.00039-5.

Nisio MD, Van Es, Büller HR (2016). Deep vein thrombosis and pulmonary

embolism

Lancet J. 388, No. 10063, p3060–3073,

Ng, T.M.H., Tsai, F., Khatri, N., Barakat, M.N. & Elkayam, U. (2010) Venous

thromboembolism in hospitalized patients with heart failure incidence,

prognosis, and prevention. Circ Heart Fail. Jan;3(1):165-73. [Online] 3 (1),

165–173. Available from: doi:10.1161/CIRCHEARTFAILURE.109.892349.

Noble, S. & Pasi, J. (2010). Epidemiology and pathophysiology of cancer-associated

thrombosis. Br J Cancer. Apr 13;102 Suppl 1:S2-9. [Online] 102 (S1), S2–S9.

Available from: doi:10.1038/sj.bjc.6605599

O’Donnell, J., Boulton, F.E., Manning, R.A. & Laffan, M.A. (2002). Amount of H

antigen expressed on circulating von Willebrand factor is modified by ABO

blood group genotype and is a major determinant of plasma von Willebrand

factor antigen levels. Arterio, thro, and vasc biology. [Online] 22 (2), 335–341.

Available from: http://www.ncbi.nlm.nih.gov/pubmed/11834538 [Accessed: 27

June 2016]

Olson ST, Björk I (1994). Regulation of thrombin activity by antithrombin and

heparin. Sem. Thromb. Hemost. 20 (4): 373–409.

Ota, S., Wada, H., Abe, Y., Yamada, E., Sakaguchi, A., Nishioka, J., et al. (2008)

Elevated Levels of Prothrombin Fragment 1 + 2 Indicate High Risk of

Thrombosis. Sage J. [Online] 14 (3), 279–285. Available from:

doi:10.1177/1076029607309176.

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

108

Okamoto, T., Tanigami, H., Suzuki, K. & Shimaoka, M. (2012). Thrombomodulin: A

bifunctional modulator of inflammation and coagulation in sepsis. Crit Care

Res Pract. 2012;2012:614545. [Online] 2012 (Dic). Available from:

doi:10.1155/2012/614545.

Piazza, G., Goldhaber, S.Z., Kroll, A., Goldberg, R.J., Emery, C. & Spencer, F.A.

(2012) Venous thromboembolism in patients with diabetes mellitus. American J

Med. [Online] 125 (7), 709–716. Available from: doi:10.1016/S0735-

1097(12)61875-0.

Pop, T. R., Crişan, S., Chirilă, D. N., & Buzoianu, A. D. (2013). Risk factors for deep

vein thrombosis in surgical patients. Int. Jour. Bioflux. 5(3), 99–102.

Pulivarthi S, Gurram KM. (2014). Effectiveness of D-dimer as a screening test for

venous thromboembolism: An update. North American J. 6:10; 491-499

Raffini L.J., Scott P.J., Montgomery R.R. (2011). Hemorrhagic and thrombotic

diseases. Nelson Textbook of Pediatrics, pp.1693–1722. Kliegman.

Philadelphia. Elsevier

Rachel E J, Roach, Willem M. Lijfering, Frits R. Rosendaal, Suzanne C. Cannegieter,

and Saskia Le Cessie., (2014). Sex difference in risk of second but not of first

venous thrombosis: Paradox explained. Circulation J. 129(1), pp.51–56.

Rodak B.F., (2002). Hematology. Clinical Principal and Applications. Philadelphia.

Saunders Company.

Rosendaal, F.R. & Reitsma, P.H. (2009) Genetics of venous thrombosis. J Thromb

and Haemost. [Online] 7 (SUPPL. 1), 301–304. Available from:

doi:10.1111/j.1538-7836.2009.03394.x.

Ruggeri Z. M., Orje J. N., Habermann R., Federici A. B. (2017). Activation-

independent platelet adhesion and aggregation under elevated shear stress.

Blood J. 108(6), 1903–1911. Available at https://doi.org/10.1182/blood-2006-

04-011551.

Sastroasmoro, S dan Ismael, S. (2008). Dasar-dasar Metodologi Klinis, edisi ke-3,

Sagung Seto, Jakarta: 302-330

Satria, RD. (2016). Perbandingan Kadar Fibrinopetida A pada Trombosis Vena

Dalam Dibanding Non-Trombosis Vena Dalam. Tesis. Patologi Klinik, Fakultas

Kedokteran Universitas Gadjah Mada. Yogyakarta

Schafer, A.I., (2016). 176 - Thrombotic Disorders: Hypercoagulable States Twenty

Fifth Edition., Elsevier Inc. Available at: http://dx.doi.org/10.1016/B978-1-

4557-5017-7.00176-8.

Scott, J.P., Montgomery, R.R., (2011). Hereditary Clotting Factor Deficiencies in:

Nelson Textbook of Peidatrics. Kliegman. nineteenth edition. Ed. Phildelphia.

Saunders Elsevier.

Sekiya, A., Hayashi, T., Kadohira, Y., Shibayama, M., Tsuda, T., Jin, X. Morishita,

E. (2017). Thrombosis Prediction Based on Reference Ranges of Coagulation-

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

109

Related Markers in Different Stages of Pregnancy. Clin Appl Thromb Hemost.

23(7), 844–850. https://doi.org/10.1177/1076029616673732

Sherwood. (2001). Trombosit dan Hemostasis. In Fisiologi Manusia dari Sel ke

Sistem. EGC, pp. 356–363. Jakarta.

Simon D., Kunicki T., Nugent D. (2008). Platelet Function Defect. J compilation,

14:1240-1249.

Smith., (2009). The cell-based model of coagulation: State-Of-The-Art Review. J Vet

Emergency, 19(1), pp.3–10.

Sørensen, H.T., Mellemkjær, L., Olsen, J.H. & Baron, J.A. (2000). Prognosis Of

Cancers Associated With Venous Thromboembolism. England J med.

3431846–1850.

Sukorini U. (2016). Faktor Risiko Hiperkoagulabilitas dan Indeks Trombosis pada

Trombosis Vena Dalam. Disertasi. Patologi Klinik, Fakultas Kedokteran

Universitas Gadjah Mada. Yogyakarta

Susanto, A.P., Krisnanda, C., Ong, H., Pratama, D. & Soeparwata, R. (2014).

Incidence of venous thromboembolism among patients who underwent major

surgery in a public hospital in Singapore. Med J Indones. 23 (1), 36–41.

Tambunan, K.L., Hutagalung, E.U., Sukrisman, L., Saleh, I. & Gunawan, S.B.

(2009). Venous thromboembolism in 13 Indonesian patients undergoing major

orthopedic surgery. Med J Indones. 18 (4), 249–256.

Van Geest-Daalderop, J.H.H., Mulder, A.B., Leandra, J.M., Winter, B., Hoekstra,

M.M.C.L., Van Den Besselaar, A.M.H.P., (2005). Preanalytical Variables and

Off-Site Blood Collection. Clinc hem. 51: 3.

Vatsyayan R, Kothari H, Mackman N. (2014). Inactivation of factor VIIa by

antithrombin in vitro, ex vivo and in vivo: Role of tissue factor and endothelial

cell protein C receptor, PLoS ONE 9(8):e103505.

Vedantham, S. et al., (2014). Quality improvement guidelines for the treatment of

lower-extremity deep vein thrombosis with use of endovascular thrombus

removal. J Vasc and Inter Radiology, 25(9):1317–1325. Available at:

http://dx.doi.org/10.1016/j.jvir.2014.04.019.

Velopulos & Haut., (2016). Venous Thromboembolism : Prevention , Diagnosis , and

Treatment Eleventh Edition., Elsevier Inc. Available at:

http://dx.doi.org/10.1016/B978-1-4557-4007-9.00188-6.

Versteeg, H.H., Heemskerk, J.W.M., Levi, M. & Reitsma, P.H. (2013). New

fundamentals in hemostasis. Physiol rev. [Online] 93 (1), 327–358. Available

from: doi:10.1152/physrev.00016.2011.

Weitz, J.I. (2006) Emerging themes in the treatment of venous thromboembolism.

Thromb Haemost. [Online] 96239–241. Available from: doi:10.1160/TH06-08-

443.

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/

110

Wells et al. , (1995). Accuracy of clinical assessment of deep-vein thrombosis. Lancet

J. 345:1326–1330.

Wells, P.S., Anderson, D.R., Rodger, M., Forgie, M., Kearon, C., Ph, D., et al.

(2003). Evaluation of d -Dimer in the Diagnosis of Suspected Deep-Vein

Thrombosis. Engl J Med. 349 (13), 1227–1235

Wolberg, A.S., Aleman, M.M., Leiderman, K. & Machlus, K.R. (2012). Procoagulant

Activity in Hemostasis and Thrombosis: Virchow’s Triad Revisited. Anest and

analg J. [Online] 114 (2), 275–285. Available from:

doi:10.1213/ANE.0b013e31823a088c.Procoagulant [Accessed: 20 June 2016].

Yamada, S.M., Tomita, Y., Murakami, H. & Nakane, M. (2016) Deep vein

thrombosis in the lower extremities in comatose elderly patients with acute

neurological diseases. Yonsei Med J. [Online] 57 (2), 388–392. Available from:

doi:10.3349/ymj.2016.57.2.388.

Yang, G., Meng, F., Liu, Y., Kong, L. & Shen, Y. (2015) Diabetes mellitus and risk

of deep vein thrombosis after total knee replacement : a meta-analysis of cohort

studies. Int J Clin Exp Med. 8 (6), 9086–9092.

Yusuf, H.R., Reyes, N., Zhang, Q.C., Okoroh, E.M., Siddiqi, A.-E.-A. & Tsai, J.

(2014). Hospitalizations of adults ≥60 years of age with venous

thromboembolism. Clin Appl Thromb Hemost. [Online] 20 (2), 136–142.

Available from: doi:10.1177/1076029613493659 [Accessed: 20 June 2016].

Zeidan, A.M., Forde, P.M. & Streiff, M.B. (2014). 35 – Diagnosis, Treatment, and

Prevention of Cancer-Associated Venous Thromboembolism Fifth Edit.,

Elsevier Inc. Available at:

http://www.sciencedirect.com/science/article/pii/B9781455728657000357

KORELASI ANTARA KOMPLEKS TROMBIN-ANTITROMBIN (TAT) DENGAN D-DIMER PADA PASIENTROMBOSIS VENA DALAM(TVD) RAEHANUL BAHRAENUniversitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/